Ipren pain reliever

Ipren is a well-established brand of ibuprofen used extensively across Northern Europe for pain relief, fever reduction, and anti-inflationary purposes. It was originally launched by the Swedish pharmaceutical company Pharmacia. The brand gained significant cultural recognition in Sweden through its iconic commercials featuring the 'Ipren-man'.

Manufacturing for Ipren typically occurs in various European facilities depending on the specific product format, such as tablets, gels, or suppositories. Following a series of pharmaceutical industry mergers, the brand moved from Pharmacia to Pfizer. In 2019, Pfizer and GSK formed a joint venture for their consumer healthcare divisions, which eventually spun off into an independent company named Haleon in 2022. Today, Haleon manages the Ipren brand globally as a leading player in the consumer health sector.